Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00747461 · ClinicalTrials.gov registry record · Phase 4
Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")
A Phase 4 study, sponsored by CSA Medical.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT00747461: Clinical Trial Phase 4 study, sponsored by CSA Medical.
NCT00747461 is a Phase 4 study that was terminated before completion, run by CSA Medical. The registered enrollment target is 5 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00747461, a Phase 4 study, was terminated before completion, sponsored by CSA Medical.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety, effectiveness, and side effects of the CryoSpray AblationTM System (CryoSpray AblationTM, "CSA" or "cryospray therapy") to treat benign airway disease in the lung using liquid nitrogen sprayed through a catheter via flexible fiber optic bronchoscopy (FFB)
Interventions
- DEVICE CryoSpray Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-03 |
| Phase | Phase 4 |
Why NCT00747461 stopped before completion
NCT00747461 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which CryoSpray Ablation is the first listed.
NCT00747461 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00747461 about?
NCT00747461 is a clinical study titled "Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")". The purpose of this study is to evaluate the safety, effectiveness, and side effects of the CryoSpray AblationTM System (CryoSpray AblationTM, "CSA" or "cryospray therapy") to treat benign airway disease in the lung using liquid nitrogen sprayed through a catheter via flexible fiber optic bronchosco...
What is the current status of trial NCT00747461?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2008-10. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00747461?
The interventions under investigation include: CryoSpray Ablation (DEVICE).
Who is sponsoring clinical trial NCT00747461?
This trial is sponsored by CSA Medical, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00747461's enrollment target sits among peer trials
5 1989th of 2000 higher than 7 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia